Kirsten Hampton, MD
Family Medicine · Macon, GANPI 1164598710
Payments from drug & device makers
Across 396 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$896
- AstraZeneca$874
- Novo Nordisk$686
- Lilly USA, LLC$567
- Boehringer Ingelheim$457
- Amgen$327
- plus $3K from 32 others
What the payments were for
- Food & beverage$6,349100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $896 |
| AstraZeneca | 54 | $874 |
| Novo Nordisk | 63 | $686 |
| Lilly USA, LLC | 39 | $567 |
| Boehringer Ingelheim | 27 | $457 |
| Amgen(2 entities) | 19 | $327 |
| Pfizer | 16 | $322 |
| GSK | 14 | $261 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $174 |
| Bayer | 12 | $165 |
| Otsuka America Pharmaceutical, Inc. | 6 | $144 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $120 |
| Sanofi-aventis U.S. LLC | 6 | $108 |
| Merck | 7 | $105 |
| Abbott | 5 | $103 |
| Amarin Pharma, Inc. | 5 | $83 |
| Corcept Therapeutics | 4 | $81 |
| Bausch Health US, LLC | 5 | $76 |
| Xeris Pharmaceuticals, Inc. | 3 | $60 |
| Biohaven Pharmaceuticals, Inc. | 3 | $60 |
| Johnson & Johnson | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| Idorsia Pharmaceuticals US Inc | 3 | $44 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| Exact Sciences | 2 | $39 |
| Lundbeck LLC | 1 | $34 |
| Novartis | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Abiomed | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Eisai Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
How this compares
$6,349 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 67 | $51,834 |
| OzempicSemaglutide | 30 | $38,346 |
| TrulicityDulaglutide | 22 | $31,772 |
| FarxigaDapagliflozin Propanediol | 26 | $20,173 |
| MounjaroTirzepatide | 17 | $19,848 |
| JardianceEmpagliflozin | 18 | $19,087 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $16,424 |
| MyrbetriqMirabegron | 23 | $15,321 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 223 | $4,481 |
| SynthroidLevothyroxine Sodium | 35 | $3,418 |
| Colesevelam Hcl | 19 | $2,880 |
| Bupropion XlBupropion Hcl | 28 | $1,914 |
| Omeprazole | 135 | $1,872 |
| Gabapentin | 135 | $1,841 |
| Duloxetine Hcl | 78 | $1,646 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $322 | $51,83467 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $567 | $51,62039 claims |
| Novo NordiskOzempic | $686 | $38,34630 claims |
| AstraZenecaFarxiga | $874 | $20,17326 claims |
| Boehringer IngelheimJardiance | $457 | $19,08718 claims |
| GSKTrelegy Ellipta | $261 | $16,42421 claims |
| Astellas Pharma US IncMyrbetriq | $16 | $15,32123 claims |
| AbbVieSynthroid | $896 | $3,41835 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Macon
- Frederick BurtonMacon$66K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.